Chloroplasts: Transforming Biopharmaceutical Manufacturing - The primary development model for producing human recombinant proteins in tobacco is based on green tissue (leaf) biomass processing. - Bi

ADVERTISEMENT

Chloroplasts: Transforming Biopharmaceutical Manufacturing
The primary development model for producing human recombinant proteins in tobacco is based on green tissue (leaf) biomass processing.


BioPharm International


6. Sidorov VA, Kasten D, Pang SZ, Hajdukiewicz PT, Staub JM, Nehra NS. Technical advance: stable chloroplast transformation in potato: use of green fluorescent protein as a plastid marker. Plant J. 1999; 19:209-216.

7. Boynton JE, Gilham NW, Harris EH, Hosler JP, Johnson AM, Jones AR, et al. Chloroplast transformation in Chlamydomonas with high velocity microprojectiles. Science 1988; 240:1534-1538.

8. Daniell H, Vivekananda J, Nielsen BL, Ye GN, Tewari, KK, Sanford JC. Transient foreign gene expression in chloroplast of cultured tobacco cells after biolistic delivery of chloroplast vector, Proc. Nat'l Acad Sci. 1990; 87:88-92.

9. Daniell H. Medical Molecular Pharming: Therapeutic recombinant antibodies, biopharmaceuticals, and edible vaccines in transgenic plants engineered via the chloroplast genome. In R. M. Goodman (Ed.), Encyclopedia of Plant and Crop Science. New York: Marcel Decker; 2004.p. 704-710. .

10. Daniell H, Khan MS, Allision L. Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology. Trends Plant Sci. 2002; 7: 84-91.

11. Daniell H. Foreign gene expression in chloroplasts of higher plants mediated by tungsten particle bombardment. Methods Enzymol. 1993; 217:536-56.

12. Daniell H. Molecular strategies for gene containment in transgenic crops, Nat Biotechnol. 2002; 20:581-586.

13. Kumar S, Dhingra A, Daniell H. Plastid expressed betaine aldehyde dehydrogenase gene in carrot-cultured cells, roots and leaves confers enhanced salt tolerance. Plant Physiol. 2004 September issue.

14. Ruiz ON, Hussein, HS, Terry N, Daniell H. Phytoremediation of organomercurial compounds via chloroplast genetic engineering. Plant Physiol. 2003; 132:1344-1352.

15. Davis D and Nelson M, eds. Tobacco - production, chemistry and technology, Malden (MA). Blackwell Science; 1999.

16. Glacken M. Plant transgenics vs. CHO bioreactor culture: an objective comparison for monoclonal antibody production, 8th International Conference on Antibody Production and Downstream Processing; 2002; San Diego, CA.

17. Mulesky M. Chlorogen Inc. internal data. 2003 Sept.

18. FDA, Guidance for Industry: Drugs, biologics, and medical devices derived from bioengineered plants for use in humans and animals. Federal Register 2002; 67: 57828, Docket No. 02D-0324.

19. Palme, H, and Winberg G., Arch Pharm, 1916; 254:537.

20. Goldschmidt-Clermont M. Transgenic expression of aminoglycoside adenine transferase in the chloroplast: a selectable marker of site-directed transformation of chlamydomonas. Nuc Acid Res 1991; 19:4083-4089.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here